Connect Biopharma (CNTB) director linked fund reports 12M-share holding
Connect Biopharma Holdings Ltd director James Huang has filed an initial Form 3, indicating an indirect beneficial ownership of 12,000,000 Ordinary Shares through Panacea Venture Healthcare Fund II, L.P. While Huang may be deemed to share beneficial ownership due to his ownership chain with entities related to the fund, he explicitly disclaims such beneficial ownership, clarifying that the holding is at the fund level. This filing provides transparency regarding significant shareholdings linked to company leadership.
MAR 11·Springfield News-Leader▲
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies will broadcast interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on its "RedChip Small Stocks, Big Money™" program on Bloomberg TV. The show will air this Saturday, November 15, at 7 p.m. ET. Interviews will feature the CEOs discussing advancements in treating severe respiratory diseases and expanding portfolios of utility-scale battery energy storage systems, respectively.
NOV 24·GlobeNewswire→
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
SAN DIEGO, Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Connect Biopharma Holdings Limited ( Nasdaq: CNTB ) ( "Connect Biopharma", "Connect", or the "Company" ) , a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that ...
